Announcement:

New scientific publication in collaboration with the University of Newcastle on modelling Stargardt disease (STGD1) in vitro with retinal organoids (RO) to unravel genotype-phenotype correlations

Find out more

Home › Resources › Scientific publications › In vitro platforms for de-risking nephrotoxicity during drug development

In vitro platforms for de-risking nephrotoxicity during drug development

Published

25th March, 2020

Share on social media:

Don't miss out on our latest innovations: follow us on Linkedin

View this resource

Please click the button below to download this resource.

Download Now

Book a Call